Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.45 (6.87%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £8.36m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

19 Jan 2026 12:15

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, January 19

19 January 2026

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2025 (the “Period”).

Chairman’s Statement

A difficult first half to the Company’s year has been a feature of recent years, with 2025 being no exception, particularly with the SME market being challenging. However, the market started to pick up in November 2025, and there has been a healthy new business pipeline developing in recent months.

During the six months ended 31 October 2025, the Company generated a gross profit of £55,310 (2024: £103,468) and delivered an operating loss of £177,066 (2024: loss of £138,485 ), resulting in an overall loss before tax of £176,515 (2024: loss of £178,261).

The Company’s balance sheet shows a net asset value of £3,063,198 (2024: £3,183,537), representing 2.56p (2024: 3.01p) of value per share in issue. The Board remains positive about the investments that it holds in its client companies, and in particular its core investment in Weardale Lithium.

Whilst there have been delays in completing some advisory projects during the Period, on a positive note, Marechale has in the last few months completed both debt and equity growth round transactions for Wright Brothers, the UK’s leading premium fish wholesaler and restaurant operator, KBH, one of the UK’s leading ‘out of home’ media companies on the UK’s railways and cinemas, Weardale Lithium, which has received planning for the UK’s first Direct Lithium Extraction plant and Chestnut Inns, one of the UK’s leading premium inn operators.

Cash at bank as at 31 October 2025 was £228,593 (2024: £223,700). However, in the months since the end of the Period, and based on the recent transactions that Marechale has completed, the Company has grown its cash at bank to £312,000 as at 14 January 2026.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals.

This plan to continue to develop Marechale’s strategic partnerships in order to enhance shareholder value, and develop new funding partners alongside its traditional investor relationships, has culminated in the successful completion of a placing in Marechale shares in October (as previously announced); this brought in two new strategic investors as well, in addition to all the Company’s directors investing too.

Marechale Capital continues to see interesting corporate finance and advisory projects; the Board believes despite the challenges of the last few years, that the SME market is looking more positive, and that there is a recognition of value in UK growth companies, particularly with new initiatives for the AIM markets, the Enterprise Investment Scheme (EIS), and the move to encourage more private and institutional funding into smaller UK companies.

Whilst the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will continue to be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term, where the Company can generate more value enhancing warrant and founding equity holdings alongside advisory cash fees. The Board is also hoping to agree terms on further strategic partnerships, and is in a number of advanced conversations with different parties.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Income Statement (unaudited)
6 months ended 31 October 2025 2024
£ £
Revenue 111,932 148,500
Cost of sales (56,622) (45,032)
Gross profit 55,310 103,468
Administrative expenses (232,376) (241,953)
Operating loss (177,066) (138,485)
Exceptional credit 600 10,316
Loss on disposal of investments - (49,837)
Interest paid (49) (255)
(Loss) before tax (176,515) (178,261)
Taxation - -
(Loss) after tax (176,515) (178,261)
(Loss) per share
(Pence) (Pence)
- Basic (0.17) (0.17)
- Diluted (0.17) (0.17)

Balance Sheet (unaudited)
As at 31 October 31 October
2025 2024
Current assets
Available for sale investments 2,807,829 2,939,660
Trading investments 58,800 49,953
Trade and other receivables 91,172 52,856
Cash and cash equivalents 228,593 223,712
3,186,394 3,266,181
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(110,811)

(4,885)

(7,500)

(54,338)

(10,806)

(10,000)

Total current liabilities (123,196) (75,144)
Net current assets 3,063,198 3,191,037
Bounce-back Loan – long-term - (7,500)
Net assets 3,063,198 3,183,537
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

955,530

575,790

847,530

481,290

Reserve for own shares (50,254) (50,254)
Retained profits/ (losses) 1,403,817 1,739,397
Reserve for share based payments 178,315 165,574
3,063,198 3,183,537
Cash Flow Statement (unaudited)
6 months ended 31 October 31 October
2024
£
Net cash from operating activities
Loss after tax (176,515) (178,261)
Reverse exceptional credits (600) (10,316)
Loss of disposal of investments - 49,837

Provision for share based payments

Reverse interest paid

-

49

15,406

255

Operating cash flows before movements in working capital (177,066) (123,079)
Movement in working capital
Decrease/ (increase) in receivables 13,852 (7,950)
(Decrease)/ Increase in payables (17,795) 3,108
Net movement in working capital (3,942) (4,842)
Operating cash out-flow (181,009) (127,921)
Investment activities
Expenditure on available for sale investments - -
Proceeds from sale of investments and options - 108,692
Cash flow from investing activities - 108,692

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

202,500

(5,000)

(48)

197,452

-

(5,000)

(255)

(5,255)

Net Increase / (decrease) in cash and cash equivalents 16,443 (24,484)
Cash and cash equivalents at start of the period 212,150 248,196
Cash and cash equivalents at end of the period 228,593 223,712
Increase / (decrease) in cash and cash equivalents 16,443 (24,484)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.